Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]
In development
Reference number: GID-TA11484
Expected publication date: TBC
Please note that following on from information received from the company, which NICE and NHS England must now consider, further information regarding the timelines for this appraisal will be available in due course.
In the meantime, NICE will continue to monitor the situation and will provide an update as and when the situation changes.